MME-29071-71084
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 553 / MN
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Joint pains, Muscle or body aches, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-28
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-05-12
- 2021-05-20
-
2021-10-22
Survey response — 6 months, dose 2MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSVMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 6 months, dose 2
Symptoms: RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release